CLIFF.US Cordlife Group Limited

Healthcare Biotechnology USA Stocks
0.1283 USD
Close of Nov 13, 2026
0.0689 0.1505
Market cap
USD 32.9M
P/E
-
P/B
0.42x
ROE
-5.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CLIFF.US undervalued?

Graham number

The Graham number of Cordlife Group Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cordlife Group Limited fundamental analysis

No fundamental analysis for Cordlife Group Limited yet.

Cordlife Group Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cordlife Group Limited

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric visio…

Full company profile